A running vest is the best way to add core warmth without overdoing it. Here are our top expert picks for 2025.
Cheeky perfume, stained glass window film, cow print clogs, and *also* some useful stuff that's all well worth a gander. View ...
Insiders who bought US$126.0k worth of 60 Degrees Pharmaceuticals, Inc.'s (NASDAQ:SXTP) stock at an average buy price of US$1.27 over the last year may be disappointed by the recent 24% decrease ...
WASHINGTON, Feb. 06, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new medicines for ...
60 Degrees Pharmaceuticals (SXTP) announced the approval of an Investigational Review Board, IRB, sanctioned Phase II clinical study. The study will evaluate the efficacy and safety of the ARAKODA ...
Insiders who bought US$126.0k worth of 60 Degrees Pharmaceuticals, Inc.'s (NASDAQ:SXTP) stock at an average buy price of US$1.27 over the last year may be disappointed by the recent 24% decrease in ...
Enrollment expected to commence Q3 2025. WASHINGTON, Jan. 28, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on ...
WASHINGTON, Feb. 06, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new medicines for infectious ...
60 Degrees Pharmaceuticals, Inc. announced the approval of an Investigational Review Board (IRB) for a Phase II clinical study aimed at evaluating the efficacy and safety of tafenoquine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback